Search

Your search keyword '"Cornel, Jan H."' showing total 136 results

Search Constraints

Start Over You searched for: Author "Cornel, Jan H." Remove constraint Author: "Cornel, Jan H." Database Unpaywall Remove constraint Database: Unpaywall
136 results on '"Cornel, Jan H."'

Search Results

1. Invasive coronary imaging of inflammation to further characterize high-risk lesions: what options do we have?

2. Abstract 17748: Lipoprotein(a) and Oxidized Phospholipids on Lipoproteins and Cardiovascular Outcomes in Patients With Chronic Coronary Syndrome Treated With Colchicine

4. Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial

6. Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements

7. Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial

8. European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction

10. The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial

11. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

12. Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2

13. Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease

15. Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy

16. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome

18. Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials

22. Colchicine in Patients with Chronic Coronary Disease

24. Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein

26. ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial

27. The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics

30. International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS

31. Ticagrelor in Patients with Stable Coronary Disease and Diabetes

36. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

37. P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes

43. Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease

44. Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

45. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

46. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

47. Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes

48. Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes

49. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients

50. Relationship of Platelet Reactivity With Bleeding Outcomes During Long‐Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non‐ST‐Segment Elevation Acute Coronary Syndromes

Catalog

Books, media, physical & digital resources